Skip to main content
JSW Dulux Limited logo

JSW Dulux Limited — Investor Relations & Filings

Ticker · JSWDULUX ISIN · INE133A01011 BSE.NS Manufacturing
Open in API
Filings indexed 2,253 across all filing types
Latest filing 2026-01-09 Board/Management Inform…
Country IN India
Listing BSE.NS JSWDULUX

About JSW Dulux Limited

https://www.jswpaints.in/

JSW Dulux Limited specializes in the development, manufacture, and distribution of a comprehensive range of decorative and industrial coating solutions. The company’s portfolio includes interior and exterior emulsions, protective finishes, enamels, and specialized wood coatings designed for both residential and commercial applications. Utilizing advanced chemical formulations, the organization focuses on delivering high-performance products characterized by durability, color precision, and environmental sustainability. Key offerings feature low-VOC compositions, weather-resistant technologies, and anti-microbial properties. The company serves a broad market spectrum, providing technical coating systems for infrastructure projects alongside consumer-grade paints. Its operations emphasize innovation in surface protection and aesthetic enhancement through rigorous research and development.

Recent filings

Filing Released Lang Actions
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal communication from Akzo Nobel India Limited dated 9th January 2026 addressed to stock exchanges (BSE and NSE). It announces changes in the company's board of directors, including appointments and re-designations of directors. The document includes detailed profiles of the new appointees and disclosures required under SEBI regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on board and management changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length (11,813 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2026-01-09 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal communication from Akzo Nobel India Limited dated 9th January 2026 addressed to stock exchanges (BSE and NSE). It announces changes in the company's board of directors, including appointments and re-designations of directors. The content includes detailed profiles of the new appointees and their terms, as well as compliance with SEBI regulations regarding disclosures. There is no financial data, earnings information, or report publication mentioned. The primary focus is on board changes, which aligns with the category for announcements of changes in the company's board or senior management. Therefore, the document fits the category 'Board/Management Information' (MANG). The document length is substantial and contains detailed information about the directors, confirming it is not a brief announcement or a report publication notice.
2026-01-09 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is a formal communication from Akzo Nobel India Limited dated 9th January 2026, addressed to stock exchanges (BSE and NSE). It announces changes in the company's board of directors, including appointments and re-designations of directors. The content includes detailed profiles of the new appointees and disclosures required under SEBI regulations. There is no financial data, earnings information, or report publication mentioned. The document is clearly about changes in the company's board and senior management positions, fitting the category of Board/Management Information (MANG). The document length (11,813 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2026-01-09 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from Akzo Nobel India Limited informing about a scheduled Board of Directors meeting to consider and approve un-audited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025. It is a notification of an upcoming board meeting and not the actual financial results or report. The document is short (1808 characters) and serves as an announcement rather than containing substantive financial data or analysis. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about a board meeting and upcoming financial results approval, not the financial report itself.
2026-01-09 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 90% confidence The document is a compliance certificate issued under SEBI (Depositories and Participants) Regulations, 2018, submitted by the Company’s Registrar and Transfer Agent to the stock exchanges. It does not contain substantive financial statements or earnings data, but is an attestation/certification letter. Under the certification rule, such officer certifications or regulatory compliance confirmations should be classified as Regulatory Filings (RNS).
2026-01-09 English
Updates
Regulatory Filings
2026-01-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.